Nath Bio-Genes (India) Limited (NATHBIOGEN) — Cash Flow Quality Index
Nath Bio-Genes (India) Limited (NATHBIOGEN) has a Cash Flow Quality Index of -2.71x as of September 2025. Operating cash flow of Rs-1.09 Billion is below net income of Rs400.34 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Nath Bio-Genes (India) Limited (NATHBIOGEN) investment intensity to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Nath Bio-Genes (India) Limited Cash Flow Quality Index (2013–2025)
Historical Cash Flow Quality Index for Nath Bio-Genes (India) Limited across 12 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check NATHBIOGEN tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Nath Bio-Genes (India) Limited (2013–2025)
Year-by-year earnings quality comparison for Nath Bio-Genes (India) Limited. For live market cap and the full company financial profile, see market value of Nath Bio-Genes (India) Limited.
| Year | Quality Index | Operating CF (INR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 0.46x | Rs175.81 Million | Rs386.00 Million | ▼ -73.2% |
| 2024 | 1.70x | Rs614.80 Million | Rs361.70 Million | ▲ +60.2% |
| 2023 | 1.06x | Rs383.67 Million | Rs361.64 Million | ▲ +5310.2% |
| 2021 | 0.02x | Rs11.13 Million | Rs567.51 Million | ▼ -90.0% |
| 2020 | 0.20x | Rs94.74 Million | Rs485.08 Million | ▲ +134.5% |
| 2019 | -0.57x | Rs-219.89 Million | Rs388.68 Million | ▲ +63.8% |
| 2018 | -1.56x | Rs-469.84 Million | Rs300.54 Million | ▼ -883.3% |
| 2017 | 0.20x | Rs33.43 Million | Rs167.53 Million | ▲ +121.5% |
| 2016 | -0.93x | Rs-141.68 Million | Rs152.34 Million | ▼ -462.8% |
| 2015 | 0.26x | Rs67.55 Million | Rs263.53 Million | ▼ -56.5% |
| 2014 | 0.59x | Rs150.28 Million | Rs255.13 Million | ▼ -49.0% |
| 2013 | 1.16x | Rs142.11 Million | Rs122.96 Million | — |